Published in Neurology on August 19, 2015
Molecular subtyping and improved treatment of neurodevelopmental disease. Genome Med (2016) 0.79
Impaired neuronal KCC2 function by biallelic SLC12A5 mutations in migrating focal seizures and severe developmental delay. Sci Rep (2016) 0.76
Gene Panel Testing in Epileptic Encephalopathies and Familial Epilepsies. Mol Syndromol (2016) 0.76
De novo and inherited SCN8A epilepsy mutations detected by gene panel analysis. Epilepsy Res (2016) 0.75
SCN3A deficiency associated with increased seizure susceptibility. Neurobiol Dis (2017) 0.75
Phenotypic Variability from Benign Infantile Epilepsy to Ohtahara Syndrome Associated with a Novel Mutation in SCN2A. Mol Syndromol (2016) 0.75
Understanding Genotypes and Phenotypes in Epileptic Encephalopathies. Mol Syndromol (2016) 0.75
Genetics and genotype-phenotype correlations in early onset epileptic encephalopathy with burst suppression. Ann Neurol (2017) 0.75
Locus Heterogeneity in Epilepsy of Infancy with Migrating Focal Seizures. Epilepsy Curr (2016) 0.75
Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy. Neurology (2016) 0.75
The influence of sodium on pathophysiology of multiple sclerosis. Neurol Sci (2017) 0.75
Phenytoin-responsive epileptic encephalopathy with a tandem duplication involving FGF12. Neurol Genet (2017) 0.75
Autism spectrum disorder and epileptic encephalopathy: common causes, many questions. J Neurodev Disord (2017) 0.75
A Model Program for Translational Medicine in Epilepsy Genetics. J Child Neurol (2017) 0.75
Comparison and optimization of in silico algorithms for predicting the pathogenicity of sodium channel variants in epilepsy. Epilepsia (2017) 0.75
The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients. Mol Diagn Ther (2017) 0.75
De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature (2012) 13.61
Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med (2012) 10.80
Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet (2012) 8.42
A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet (1998) 4.89
KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy. Ann Neurol (2012) 4.12
Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet (2013) 3.64
De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. Am J Hum Genet (2012) 3.58
Clinical application of exome sequencing in undiagnosed genetic conditions. J Med Genet (2012) 3.33
De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet (2012) 2.86
Using whole-exome sequencing to identify inherited causes of autism. Neuron (2013) 2.74
De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies. Neurology (2009) 2.53
Sodium-channel defects in benign familial neonatal-infantile seizures. Lancet (2002) 2.43
SCN1A mutations and epilepsy. Hum Mutat (2005) 2.34
A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline. J Neurosci (2004) 2.31
The phenotypic spectrum of SCN8A encephalopathy. Neurology (2015) 2.12
Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome. Brain (2012) 1.96
Sodium channels and the neurobiology of epilepsy. Epilepsia (2012) 1.66
Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis. Hum Mol Genet (2014) 1.46
Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy. Ann Neurol (2004) 1.40
SCN2A mutations and benign familial neonatal-infantile seizures: the phenotypic spectrum. Epilepsia (2007) 1.40
Early onset epileptic encephalopathy caused by de novo SCN8A mutations. Epilepsia (2014) 1.38
Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia (1998) 1.37
SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain. Neurology (2010) 1.29
Clinical spectrum of SCN2A mutations expanding to Ohtahara syndrome. Neurology (2013) 1.19
Migrating partial seizures of infancy: expansion of the electroclinical, radiological and pathological disease spectrum. Brain (2013) 1.19
Molecular correlates of age-dependent seizures in an inherited neonatal-infantile epilepsy. Brain (2010) 1.16
A novel SCN2A mutation in family with benign familial infantile seizures. Epilepsia (2006) 1.06
Missense mutation of the sodium channel gene SCN2A causes Dravet syndrome. Brain Dev (2009) 1.01
Genotype phenotype associations across the voltage-gated sodium channel family. J Med Genet (2014) 1.00
Targeted capture and sequencing for detection of mutations causing early onset epileptic encephalopathy. Epilepsia (2013) 0.96
Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities. Epilepsia (2014) 0.93
Retrospective multiinstitutional study of the prevalence of early death in Dravet syndrome. Epilepsia (2011) 0.87
Whole genome sequencing identifies SCN2A mutation in monozygotic twins with Ohtahara syndrome and unique neuropathologic findings. Epilepsia (2013) 0.86
De novo SCN2A splice site mutation in a boy with Autism spectrum disorder. BMC Med Genet (2014) 0.84
SCN2A mutation is associated with infantile spasms and bitemporal glucose hypometabolism. Pediatr Neurol (2013) 0.83
Confirming an expanded spectrum of SCN2A mutations: a case series. Epileptic Disord (2014) 0.81
Novel de novo SCN2A mutation in a child with migrating focal seizures of infancy. Pediatr Neurol (2013) 0.80
Head stereotypies in STXBP1 encephalopathy. Dev Med Child Neurol (2013) 0.77
Acute encephalopathy with a novel point mutation in the SCN2A gene. Epilepsy Res (2012) 0.76